MediWound (MDWD) EBIT (2013 - 2025)

MediWound's EBIT history runs 13 years deep, the most recent figure standing at -$7.8 million for Q4 2025.

• In Q4 2025, EBIT fell 27.85% year-over-year to -$7.8 million; the TTM figure through Dec 2025 stood at -$25.3 million (down 30.24% YoY), while the FY2025 annual figure was -$25.3 million, down 30.24% from the prior year.
• EBIT was -$7.8 million for Q4 2025 at MediWound, down from -$6.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $2.1 million in Q4 2022 to a low of -$7.8 million in Q4 2025.
• Historically, EBIT has averaged -$4.0 million across 5 years, with a median of -$3.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBIT jumped 160.3% in 2022, then plunged 283.42% in 2023.
• A 5-year view of EBIT shows it stood at -$3.5 million in 2021, then surged by 160.3% to $2.1 million in 2022, then slumped by 283.42% to -$3.9 million in 2023, then tumbled by 56.68% to -$6.1 million in 2024, then fell by 27.85% to -$7.8 million in 2025.
• The last three EBIT figures came in at -$7.8 million (Q4 2025), -$6.5 million (Q3 2025), and -$5.7 million (Q2 2025), per Business Quant data.